Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
PBM Formulary Exclusions On The Rise, PhRMA Says
Access To Lower-Cost Insulin Affected
May 26 2022
•
By
Joseph Haas
PBMs continue excluding drugs from their standard formularies
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Drug Pricing
More from Scrip